| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.1 |